...
首页> 外文期刊>Journal of Medical Case Reports >Nitrofurantoin-induced pulmonary fibrosis: a case report
【24h】

Nitrofurantoin-induced pulmonary fibrosis: a case report

机译:呋喃妥因诱导的肺纤维化:一例报告

获取原文

摘要

Introduction Nitrofurantoin is a commonly used drug in the treatment and prevention of urinary tract infections. Many adverse effects of nitrofurantoin have been documented, including aplastic anemia, polyneuritis, and liver and pulmonary toxicity. Case presentation We describe the clinical history and the autopsy findings in a 51-year-old woman with lung fibrosis of unknown etiology. She had a history of recurrent urinary tract infections, treated with nitrofurantoin for many years. She was referred to our hospital for screening for lung transplantation because of severe pulmonary restriction and dyspnea. Unfortunately, she died as a result of progressive respiratory insufficiency. At autopsy bilateral patchy, sharply circumscribed fibrotic areas in the upper and lower lobes of the lungs were seen with honeycombing. Microscopically, end-stage interstitial fibrosis with diffuse alveolar damage was observed. Due to the atypical distribution of the fibrosis involving both the lower and upper lobes of the lung, the microscopic pattern of the fibrosis and the history of long-term nitrofurantoin use, we concluded that this drug induced the lung fibrosis. The recurrent urinary tract infections were probably caused by a diverticulum of the urinary bladder, which was discovered at autopsy. Conclusion This case shows that the use of nitrofurantoin may cause severe pulmonary disease. Patients with long-term use of nitrofurantoin should be monitored regularly for adverse pulmonary effects.
机译:简介呋喃妥因是治疗和预防尿路感染的常用药物。呋喃妥因的许多不良作用已得到记录,包括再生障碍性贫血,多发性神经炎以及肝和肺毒性。病例介绍我们描述了一名病因未知的51岁女性肺纤维化的临床病史和尸检结果。她有尿路反复感染的病史,用呋喃妥因治疗多年。由于严重的肺部限制和呼吸困难,她被转诊到我们医院进行肺移植检查。不幸的是,她因进行性呼吸功能不全而死亡。尸检时发现双侧斑片状,在蜂窝状上,下肺叶中有明显的界限性纤维化区域。显微镜下观察到末期间质纤维化伴弥漫性肺泡损伤。由于涉及肺下叶和肺上叶的纤维化的非典型分布,纤维化的微观模式以及长期使用呋喃妥因的历史,我们得出结论,该药物可诱发肺纤维化。尿路反复感染可能是由尸检发现的膀胱憩室引起的。结论该病例表明使用呋喃妥因可能导致严重的肺部疾病。长期使用硝基呋喃妥因的患者应定期监测其不良肺影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号